Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Cited by (1,001)

Items 301–400 of 1,001

1. Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling
   Yulin He, Xingrong Guo, Tingyu Lan, Jianbo Xia, Jinsong Wang, Bei Li, Chunyan Peng, Yue Chen, Xiang Hu, Zhongji Meng · 2021 · Stem Cell Research & Therapy
2. Dynamic human liver proteome atlas reveals functional insights into disease pathways
   Lili Niu, Philipp Emanuel Geyer, Rajat Gupta, Alberto Santos, Florian Meier, Sophia Doll, Nicolai J. Wewer Albrechtsen, Sabine Klein, Cristina Ortiz, Frank Erhard Uschner et al. · 2022 · Molecular Systems Biology
3. Hepatic Progenitor Cells in Action
   Savneet Kaur, Hamda Siddiqui, Mohsin H. Bhat · 2015 · American Journal Of Pathology
4. A small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury
   Ribera, Jordi, Pauta, Montse, Melgar-Lesmes, Pedro, Córdoba, Bernat, Bosch, Anna, Calvo, Maria, Rodrigo-Torres, Daniel, Sancho-Bru, Pau, Mira, Aurea, Jiménez, Wladimiro et al. · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
5. Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy
   2024
6. How Plastic Are Pericytes?
   Alexander Birbrair, Isabella da Terra Borges, Isadora F. G. Sena, Gregório Guilherme Almeida, Lindolfo da Silva Meirelles, Ricardo Gonçalves, Akiva Mintz, Osvaldo Delbono · 2017 · Stem Cells and Development
7. The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix
   Michitaka Matsuda, Ekihiro Seki · 2020 · Food and Chemical Toxicology
8. Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin
   Andrew M. Shearer, Rajashree Rana, Karyn M. Austin, James Baleja, Nga Nguyen, Andrew Bohm, Lidija Covic, Athan Kuliopulos · 2016 · Journal of Biological Chemistry
9. The Origin and Fate of Liver Myofibroblasts
   Kim, Hyun Young, Sakane, Sadatsugu, Eguileor, Alvaro, Carvalho Gontijo Weber, Raquel, Lee, Wonseok, Liu, Xiao, Lam, Kevin, Ishizuka, Kei, Rosenthal, Sara Brin, Diggle, Karin et al. · 2024 · Cellular and Molecular Gastroenterology and Hepatology
10. Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis
    Ida Falk Villesen, Samuel Joseph Daniels, Diana Julie Leeming, Morten Asser Karsdal, Mette Juul Nielsen · 2020 · Alimentary Pharmacology & Therapeutics
11. Albumin-Based Silibinin Nanocrystals Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy
    Shiqin Luo, Yuping Yang, Ting Zhao, Rongping Zhang, Changlong Fang, Yan Li, Zhirong Zhang, Tao Gong · 2023 · ACS Applied Materials & Interfaces
12. Liver endothelial cells in NAFLD and transition to NASH and HCC
    Rallia-Iliana Velliou, Aigli‐Ioanna Legaki, Polyxeni Nikolakopoulou, Nikolaos I. Vlachogiannis, Antonios Chatzigeorgiou · 2023 · Cellular and Molecular Life Sciences
13. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway
    Xiaoxue Yang, Liping Ma, Rong Wei, Tinghong Ye, Yun Ma, Tinghong Ye, JianKang Zhou, Wen Maoyao, Ruoting Men, Yong Peng et al. · 2020 · Signal Transduction and Targeted Therapy
14. Molecular pathways of liver regeneration: A comprehensive review
    Kiseleva, Yana V, Antonyan, Sevak Z, Zharikova, Tatyana S, Tupikin, Kirill A, Kalinin, Dmitry V, Zharikov, Yuri O · 2021 · World Journal of Hepatology
15. Margatoxin mitigates CCl4‑induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling
    Baoming Wu, Jun‐Da Liu, Yuanhai Li, Jun Li · 2019 · International Journal of Molecular Medicine
16. Emerging roles of ferroptosis in liver pathophysiology
    Kyu Min Kim, Sam Seok Cho, Sung Hwan Ki · 2020 · Archives of Pharmacal Research
17. Fibrotic Scar in CNS Injuries: From the Cellular Origins of Fibroblasts to the Molecular Processes of Fibrotic Scar Formation
    Maryam Ayazi, Sandra Zivkovic, Grace Hammel, Branko Stefanovic, Yi Ren · 2022 · Cells
18. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma
    Xueru Mu, Jean‐Philippe Pradère, Silvia Affò, Dianne H. Dapito, Richard A. Friedman, Jay H. Lefkowitch, Robert F. Schwabe · 2015 · Gastroenterology
19. Nanotechnology in Drug Delivery for Liver Fibrosis
    Lihong Gu, Feng Zhang, Jinhui Wu, Yuzheng Zhuge · 2022 · Frontiers in Molecular Biosciences
20. Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis
    Sam Seok Cho, Ji Hye Yang, Ji‐Hyun Lee, Jin Sol Baek, Sae‐Kwang Ku, Il Je Cho, Kyu Min Kim, Sung Hwan Ki · 2022 · Free Radical Biology and Medicine
21. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article
    Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour · 2016 · Middle East Journal of Digestive Diseases
22. Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis
    Altynbek Zhubanchaliyev, Aibar Temirbekuly, Kuralay Kongrtay, Leah C. Wanshura, Jeannette Kunz · 2016 · Frontiers in Pharmacology
23. Palmitic acid stimulates NLRP3 inflammasome activation through TLR4-NF-κB signal pathway in hepatic stellate cells
    Zhixia Dong, Qian Zhuang, Min Ning, Shan Wu, Lungen Lu, Xinjian Wan · 2020 · Annals of Translational Medicine
24. CDKN2a/p16 Antagonizes Hepatic Stellate Cell Activation and Liver Fibrosis by Modulating ROS Levels
    Fangqiao Lv, Nan Li, Ming Kong, Jun Wu, Zhiwen Fan, Dengshun Miao, Yong Xu, Qing Ye, Yutong Wang · 2020 · Frontiers in Cell and Developmental Biology
25. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells
    Xiaolong Tu, Xiuxiu Zheng, Huanan Li, Zhipeng Cao, Hanwen Chang, Shaoyuan Luan, Jie Zhu, Jiangning Chen, Yuhui Zang, Junfeng Zhang · 2015 · Toxicological Sciences
26. Therapeutic pro-fibrogenic signaling pathways in fibroblasts
    Stefania Cannito, Erica Novo, Maurizio Parola · 2017 · Advanced Drug Delivery Reviews
27. Liver fibrosis: the 2017 state of art
    Gian Paolo Caviglia, Chiara Rosso, Sharmila Fagoonee, Giorgio Maria Saracco, Rinaldo Pellicano · 2017 · Panminerva Medica
28. Fibrotic Events in the Progression of Cholestatic Liver Disease
    Hanghang Wu, Chaobo Chen, Siham Ziani, Leonard J. Nelson, Matias Antonio Avila, Yulia Alexandrowna Nevzorova, Francisco Javier Cubero · 2021 · Cells
29. Engineering in vitro models of hepatofibrogenesis
    Giuseppe Mazza, Walid Al‐Akkad, Krista Rombouts · 2017 · Advanced Drug Delivery Reviews
30. Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis
    Byeong–Moo Kim, Ahmed Maher Abdelfattah, Robin V. Vasan, Bryan C. Fuchs, Michael Y. Choi · 2018 · Scientific Reports
31. Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis
    Aveline A. Filliol, Robert F. Schwabe · 2019 · Seminars in Liver Disease
32. Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells
    Hao Shen, Han Yu, Qianyu Li, Ya-ting Wei, Jing Fu, Hui Dong, Dan Cao, Linna Guo, Lei Chen, Yuan Yang et al. · 2022 · Acta Pharmacologica Sinica
33. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
    Ji Won Park, Jung Hee Kim, Sung Eun Kim, Jang Han Jung, Myoung Kuk Jang, Sang Hoon Park, Myung Seok Lee, Hyoung Su Kim, Ki Tae Suk, Dong Joon Kim · 2022 · Biomedicines
34. Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines
    Lijun Gong, Fang Wei, Frank J. Gonzalez, Guolin Li · 2023 · Hepatology
35. Mechanosignaling via Integrins: Pivotal Players in Liver Fibrosis Progression and Therapy
    Aigul Sharip, Jeannette Kunz · 2025 · Cells
36. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
    Rudi Alberts, Elisabeth M. G. de Vries, Elizabeth C. Goode, Xiaojun Jiang, Fotis Sampaziotis, Krista Rombouts, Katrin Böttcher, Trine Folseraas, Tobias J. Weismüller, Andrew L. Mason et al. · 2017 · Gut
37. Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis
    Xin Chen, Wanxia Li, Yu Chen, Xiaofeng Li, Hai-Di Li, Huimin Huang, Fangtian Bu, Xue‐Yin Pan, Yang Yang, Cheng Huang et al. · 2018 · Cell Death and Disease
38. sGC stimulator praliciguat suppresses stellate cell fibrotic transformation and inhibits fibrosis and inflammation in models of NASH
    Katherine C. Hall, Sylvie G. Bernier, Sarah Jacobson, Guang Liu, Ping Y. Zhang, Renee Sarno, Victoria Catanzano, Mark G. Currie, Jaime L. Masferrer · 2019 · Proceedings of the National Academy of Sciences
39. New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease
    Xinghui Sun, Edward N. Harris · 2020 · American Journal of Physiology-Cell Physiology
40. Heterogeneity of Hepatic Stellate Cells in Fibrogenesis of the Liver: Insights from Single-Cell Transcriptomic Analysis in Liver Injury
    Wenjun Zhang, Simon James Conway, Ying Liu, Paige L. Snider, Hanying Chen, Hongyu Gao, Yunlong Liu, Kadir Isidan, Kevin Lopez, Gonzalo Campaña et al. · 2021 · Cells
41. Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts
    Sébastien Lepreux, Alexis Desmoulière · 2015 · Frontiers in Physiology
42. Pathobiochemical signatures of cholestatic liver disease in bile duct ligated mice
    Kerstin Abshagen, Matthias König, Andreas Hoppe, Isabell B. Müller, Matthias P A Ebert, Honglei Weng, Hermann−Georg Holzhütter, Ulrich M. Zanger, Johannes Georg Bode, Brigitte Vollmar et al. · 2015 · BMC Systems Biology
43. Pathogenesis of non-alcoholic fatty liver disease mediated by YAP
    Ping Chen, Qihui Luo, Chao Huang, Qi Gao, Like Li, Jingfei Chen, Bing Chen, Wentao Liu, Wen Zeng, Zhengli Chen · 2018 · Hepatology International
44. Modulation of Liver Inflammation and Fibrosis by Interleukin-37
    Steffeni Mountford, Maria Effenberger, Heidi Noll‐Puchta, Lucas Griessmair, Andrea Ringleb, Sonja Haas, Gerald Denk, Florian Paul Reiter, Doris Cooper Mayr, Charles Anthony Dinarello et al. · 2021 · Frontiers in Immunology
45. Hepatic stellate cell-specific deletion of SIRT1 exacerbates liver fibrosis in mice
    Min Li, Wenxuan Hong, Chenzhi Hao, Luyang Li, Huihui Xu, Ping Li, Yong Xu · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
46. Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1
    Le Tao, Guangyue Yang, Tiantian Sun, Jie Tao, Chan Zhu, Huimin Yu, Yalan Cheng, Zongguo Yang, Mingyi Xu, Yuefeng Jiang et al. · 2023 · Journal of Hepatology
47. Mesodermal Mesenchymal Cells Give Rise to Myofibroblasts, but Not Epithelial Cells, in Mouse Liver Injury
    Ingrid Lua, David James, Jiaohong Wang, Kasper S. Wang, Kinji Asahina · 2014 · Hepatology
48. The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration
    Ingrid Lua, Kinji Asahina · 2016 · Gut and Liver
49. Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of Smads signaling pathway
    Rui Jiang, Yujia Zhou, Sufan Wang, Nengzhi Pang, Yuanling Huang, Mingtong Ye, Ting Wan, Yun Qiu, Lei Pei, Xuye Jiang et al. · 2019 · Life Sciences
50. Hepatic stellate and endothelial cells maintain hematopoietic stem cells in the developing liver
    Yeojin Lee, Juliana S. Leslie, Ying Yang, Lei Ding · 2020 · The Journal of Experimental Medicine
51. Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis
    Kojiro Taura, Keiko Iwaisako, Etsuro Hatano, Shinji Üemoto · 2016 · Journal of Clinical Medicine
52. The apelin–APJ axis: A novel potential therapeutic target for organ fibrosis
    Shifang Huang, Linxi Chen, Liqun Lu, Lanfang Li · 2016 · Clinica Chimica Acta
53. Pentraxin‐3 modulates lipopolysaccharide‐induced inflammatory response and attenuates liver injury
    Luís Perea, Mar Coll, Lucía Sanjurjo, Delia Blaya, Adil El Taghdouini, Daniel Rodrigo‐Torres, José Altamirano, Isabel Graupera, Beatriz Aguilar‐Bravo, Marta Llopis et al. · 2017 · Hepatology
54. The Chromatin Remodeler Brg1 Integrates ROS Production and Endothelial-Mesenchymal Transition to Promote Liver Fibrosis in Mice
    Zilong Li, Baoyu Chen, Wenhui Dong, Ming Kong, Yang Shao, Zhiwen Fan, Liming Yu, Dongmei Wu, Jun Lan Lu, Junli Guo et al. · 2019 · Frontiers in Cell and Developmental Biology
55. Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis
    Shan He, Yuru Luo, Wangge Ma, X Y Wang, Chengrong Yan, Wenyang Hao, Yuan Fang, Hongyu Su, Baochang Lai, Junhui Liu et al. · 2024 · Journal of Hepatology
56. A Scalable Approach for the Generation of Human Pluripotent Stem Cell-Derived Hepatic Organoids with Sensitive Hepatotoxicity Features
    Malte Sgodda, Zhen Dai, Robert Zweigerdt, Amar Deep Sharma, Michael Ott, Tobias Cantz · 2017 · Stem Cells and Development
57. SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
    Varinder Singh Athwal, J.P. Pritchett, Jessica Llewellyn, Katherine Martin, Elizabeth M. Camacho, Sayyid Raza, Alexander Phythian‐Adams, Lindsay Birchall, Aoibheann F. Mullan, Kim Su et al. · 2017 · EMBO Molecular Medicine
58. Engineered Fibrous Networks To Investigate the Influence of Fiber Mechanics on Myofibroblast Differentiation
    Matthew D. Davidson, Kwang Hoon Song, Mu‐Huan Lee, Jessica Llewellyn, Yu Mei Du, Brendon M. Baker, Rebecca G. Wells, Jason A. Burdick · 2019 · ACS Biomaterials Science & Engineering
59. Spatial genomics: mapping human steatotic liver disease
    Kylie P. Matchett, Jasmin Paris, Sarah Amalia Teichmann, Neil Cowan Henderson · 2024 · Nature Reviews Gastroenterology & Hepatology
60. MafG/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells
    Yalan Deng, Liqing Lu, Dandan Zhu, Huajun Zhang, Ying Fu, Yuying Tan, Xuemei Tan, Ming Guo, Ye Zhang, Heping Yang et al. · 2024 · Cell Death and Differentiation
61. Role of the chemokine system in liver fibrosis: a narrative review
    Kyle L. Poulsen, Christina K. Cajigas‐Du Ross, Jarod Chaney, Laura E. Nagy · 2022 · Digestive Medicine Research
62. Aloin Attenuates Oxidative Stress, Inflammation, and CCl 4 -Induced Liver Fibrosis in Mice: Possible Role of TGF-β/Smad Signaling
    Junjie Bai, Baolin Qian, Tianying Cai, Yifan Chen, Tongxi Li, Yonglang Cheng, Ziming Wu, Chen Liu, Mingxin Ye, Yichao Du et al. · 2023 · Journal of Agricultural and Food Chemistry
63. Antifibrotics in chronic liver disease: tractable targets and translational challenges
    Prakash Ramachandran, Neil Cowan Henderson · 2016 · The Lancet. Gastroenterology & hepatology
64. Road to stemness in hepatocellular carcinoma
    Teresita del N.J. Flores-Téllez, Saúl Villa‐Treviño, Carolina Piña‐Vázquez · 2017 · World Journal of Gastroenterology
65. Inorganic Nanomaterials as Highly Efficient Inhibitors of Cellular Hepatic Fibrosis
    Fei Peng, Jie Kai Tee, Magdiel Inggrid Setyawati, Xianguang Ding, Hui Ling Yeo, Yeong Lan Tan, David Tai Leong, Han Kiat Ho · 2018 · ACS Applied Materials & Interfaces
66. Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
    Jong-Sung Park, Yumin Oh, Yong Joo Park, Ogyi Park, Hoseong S. Yang, Stephanie Slania, Laura Kathleen Hummers, Ami A. Shah, Hyoung-Tae An, Jiyeon Jang et al. · 2019 · Nature Communications
67. Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
    Helene M. Ægidius, Sanne Skovgård Veidal, Michael Feigh, Philip Hallenborg, Michele Puglia, Tune H. Pers, Niels Vrang, Jacob Jelsing, Birgitte Rahbek Kornum, Blagoy Blagoev et al. · 2020 · Scientific Reports
68. Liver macrophages: development, dynamics, and functions
    Nusse, Ysbrand, Kubes, Paul · 2025 · Cellular & Molecular Immunology
69. A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells
    Nanaho Kasahara, Yukiko Imi, Reina Amano, Masakazu Shinohara, Kumiko Okada, Yusei Hosokawa, Makoto Imamori, Chiaki Tomimoto, Jun Kunisawa, Shigenobu Kishino et al. · 2023 · Scientific Reports
70. Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease
    Robert F. Schwabe, Frank Tacke, Atsushi Sugimoto, Scott L. Friedman · 2025 · JHEP Reports
71. Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia
    Nirmala Mavila, David James, Pranavkumar Shivakumar, Marie V. Nguyen, Sarah Utley, Katrina Mak, Allison J. Wu, Shengmei Zhou, Larry L. Wang, Christopher Vendyres et al. · 2014 · Hepatology
72. Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice
    Leola N. Y. Chow, Petra Schreiner, Betina Y. Y. Ng, Bernard C. Lo, Michael R. Hughes, R. Wilder Scott, Vionarica Gusti, Samantha Lecour, Eric Simonson, Irina Manisali et al. · 2016 · PLoS ONE
73. Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activation
    Wanda Delogu, Alessandra Caligiuri, Angela Provenzano, Chiara Rosso, Elisabetta Bugianesi, Andrea Coratti, José Macías‐Barragán, Sara Galastri, Giovanni Di Maira, Fabio Marra · 2019 · Digestive and Liver Disease
74. Fibroblasts in liver cancer: functions and therapeutic translation
    Affo, Silvia, Filliol, Aveline, Gores, Gregory J, Schwabe, Robert F · 2023 · The Lancet Gastroenterology & Hepatology
75. Critical effects of long non-coding RNA on fibrosis diseases
    Yue Zhang, Gang Luo, Yi Zhang, Mengjie Zhang, Jian Zhou, Weiwu Gao, Xiuyun Xuan, Xia Yang, Di Yang, Zhiqiang Tian et al. · 2018 · Experimental & Molecular Medicine
76. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway
    Xi‐Xi Ni, Xiaoyun Li, Qi Wang, Jing Hua · 2020 · Journal of Physiology and Biochemistry
77. Retinyl esters form lipid droplets independently of triacylglycerol and seipin
    Martijn R. Molenaar, Kamlesh Kumar Yadav, Alexandre Toulmay, Tsjerk A. Wassenaar, Muriel C. Mari, Lucie Caillon, Aymeric Chorlay, Ivan Lukmantara, Maya W. Haaker, Richard Wubbolts et al. · 2021 · The Journal of Cell Biology
78. Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice
    Koop, Anja Christina, Thiele, Nina Doreen, Steins, David, Michaëlsson, Erik, Wehmeyer, Malte, Scheja, Ludger, Steglich, Babett, Huber, Samuel, Schulze zur Wiesch, Julian, Lohse, Ansgar W. et al. · 2020 · Hepatology Communications
79. Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury
    Anca Daniela Petrescu, Sharon DeMorrow · 2021 · Cells
80. Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator‐activated receptor γ
    Yan Jiang, Sheng Wang, Yuanyuan Zhao, Chengzhao� Lin, Fan Zhong, Jin Li, Fuchu He, Haijian Wang · 2015 · The FASEB Journal
81. Origin of fibrosing cells in systemic sclerosis
    Sarah Ebmeier, Valerie Horsley · 2015 · Current Opinion in Rheumatology
82. Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis
    Jung‐Yeon Kim, Hyun‐Jin An, Woon‐Hae Kim, Mi‐Gyeong Gwon, Hyemin Gu, Yoon-Yub Park, Kwan‐Kyu Park · 2017 · Molecular Therapy — Nucleic Acids
83. Fetal liver development and implications for liver disease pathogenesis
    Lotto, Jeremy, Stephan, Tabea L., Hoodless, Pamela A. · 2023 · Nature Reviews Gastroenterology & Hepatology
84. Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis
    Marie Bobowski, Clémence Boulet, Francesco Paolo Zummo, Julie Dubois‐Chevalier, Céline Gheeraert, Mohamed Bou Saleh, Jean‐Marc Strub, Amaury Farce, Maheul Ploton, Loïc Guille et al. · 2022 · Nature Communications
85. Hepatic stellate cells hold the key to liver fibrosis
    Katrina Ray · 2013 · Nature Reviews Gastroenterology & Hepatology
86. Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?
    Ningling Kang, Vijay H. Shah, Raul A. Urrutia · 2014 · Molecular Cancer Research
87. Role of hemostatic factors in hepatic injury and disease: animal models de‐liver
    Anna K. Kopec, Nikita Joshi, James P. Luyendyk · 2016 · Journal of Thrombosis and Haemostasis
88. Relevance of autophagy to fatty liver diseases and potential therapeutic applications
    Shengmin Yan, Nazmul Huda, Bilon Khambu, Xiao‐Ming Yin · 2017 · Amino Acids
89. Stromal heterogeneity in pancreatic cancer and chronic pancreatitis
    Lena Häberle, Katja Steiger, Anna Melissa Schlitter, Sami Alexander Safi, Wolfram Trudo Knoefel, Mert Erkan, Iréne Esposito · 2018 · Pancreatology
90. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
    David Fernández‐Ramos, Pablo Fernández‐Tussy, Fernando Lopitz‐Otsoa, Virginia Gutiérrez-de-Juan, Nicolás Navasa, Lucía Barbier‐Torres, Imanol Zubiete‐Franco, Jorge Simón, Agustín F. Fernández, Ander Arbelaiz et al. · 2018 · Cell Death and Disease
91. Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis
    Ming Kong, Wenxuan Hong, Yang Shao, Fangqiao Lv, Zhiwen Fan, Ping Li, Yong Xu, Junli Guo · 2019 · Journal of Molecular Medicine
92. Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells
    Vikas Gupta, Ishaan Gupta, Jiwoon Park, Yaron Bram, Robert E. Schwartz · 2020 · Gastroenterology
93. Isochlorogenic Acid A Attenuates the Progression of Liver Fibrosis Through Regulating HMGB1/TLR4/NF-κB Signaling Pathway
    Xin Liu, Kai Huang, Ru Jiao Zhang, Dan Mei, Bo Zhang · 2020 · Frontiers in Pharmacology
94. Directed differentiation of human induced pluripotent stem cells to hepatic stellate cells
    Júlia Vallverdú, Raquel A. Martínez García de la Torre, Inge Mannaerts, Stefaan Verhulst, Ayla Smout, Mar Coll, Sílvia Ariño, Teresa Rubio‐Tomás, Beatriz Aguilar‐Bravo, Celia Martínez–Sánchez et al. · 2021 · Nature Protocols
95. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma
    Hui Li · 2021 · Digestive and Liver Disease
96. Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
    Fotsitzoudis, Charalampos, Koulouridi, Asimina, Messaritakis, Ippokratis, Konstantinidis, Theocharis, Gouvas, Nikolaos, Tsiaoussis, John, Souglakos, John · 2022 · Cancers
97. Development of human iPSC-derived quiescent hepatic stellate cell-like cells for drug discovery and in vitro disease modeling
    Yuta Koui, Misao Himeno, Yusuke Mori, Yasuhiro Nakano, Eiko Saijou, Naoki Tanimizu, Yoshiko Kamiya, Hiroko Anzai, Natsuki Maeda, L L Wang et al. · 2021 · Stem Cell Reports
98. Liver Fibrosis in HIV Patients Receiving a Modern cART
    Raphael U. Mohr, Robert Schierwagen, Carolynne Schwarze‐Zander, Christoph Boesecke, Jan‐Christian Wasmuth, Jonel Trebicka, Jürgen Kurt Rockstroh · 2015 · Medicine
99. Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via αv integrin interaction
    Akiko Sugiyama, Keishi Kanno, Norihisa Nishimichi, Shoichiro Ohta, Junya Ono, Simon James Conway, Kenji Izuhara, Yasuyuki Yokosaki, Susumu Tazuma · 2016 · Journal of Gastroenterology
100. Portal myofibroblasts connect angiogenesis and fibrosis in liver
     Sara Lemoinne, Dominique Thabut, Chantal Housset · 2016 · Cell and Tissue Research